Tag Archives: PATIENTS

FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

Print this page RALEIGH, N.C.  –  May 13,  2019  –  Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA), broadening its indication to be a first-line treatment of blepharospasm (involuntary blinking) in adult patients. “Merz is proud to offer a first-line… Read More »

The other Tubs – Professor Niall Tubridy on dealing with terminal patients and having a famous brother

Neurologist Niall Tubridy Ryan Tubridy The other Tubs – Professor Niall Tubridy on dealing with terminal patients and having a famous brother Independent.ie Professor Niall Tubridy knows the look all too well. After all, it only happens “every hour or so”. He’ll be in the middle of explaining a treatment plan to a patient when… Read More »

Chi-Med, AstraZeneca’s savolitinib helps some Tagrisso-resistant EGFR lung cancer patients

ATLANTA—AstraZeneca’s Tagrisso has taken the EGFR lung cancer market by storm, but some patients develop resistance to the therapy. Enter Chi-Med. The Chinese company Sunday rolled out phase 1b results showing that certain treatment-resistant patients showed improvement after receiving a combination of Tagrisso, which targets the EGFR gene mutation, and Chi-Med’s savolitinib, a MET inhibitor… Read More »